Cancers,
Год журнала:
2023,
Номер
15(16), С. 4154 - 4154
Опубликована: Авг. 17, 2023
Patients
with
inflammatory
bowel
diseases
(IBDs),
such
as
ulcerative
colitis
and
Crohn’s
disease,
have
an
increased
risk
of
developing
colorectal
cancer
(CRC).
Although
advancements
in
endoscopic
imaging
techniques,
integrated
surveillance
programs,
improved
medical
therapies
contributed
to
a
decreased
incidence
CRC
patients
IBD,
the
rate
remains
higher
IBD
than
individuals
without
chronic
colitis.
IBD-related
CRCs
exhibit
poorer
prognosis
those
sporadic
CRCs,
owing
their
aggressive
histological
characteristics
lower
curative
resection
rate.
In
this
review,
we
present
updated
overview
epidemiology,
etiology,
factors,
strategies,
treatment
recommendations,
CRCs.
Gut,
Год журнала:
2024,
Номер
73(8), С. 1376 - 1387
Опубликована: Май 22, 2024
Background
Metabolic
disorders
and
inflammatory
bowel
diseases
(IBD)
have
captured
the
globe
during
Westernisation
of
lifestyle
related
dietary
habits
over
last
decades.
Both
disease
entities
are
characterised
by
complex
heterogeneous
clinical
spectra
linked
to
distinct
symptoms
organ
systems
which,
on
a
first
glimpse,
do
not
many
commonalities
in
practice.
However,
experimental
studies
indicate
common
backbone
mechanisms
metabolic
gut
inflammation,
emerging
evidence
suggests
an
intricate
interplay
between
IBD.
Objective
We
depict
parallels
IBD
diseases,
easily
overlooked
routine.
Design
provide
overview
recent
literature
discuss
implications
morbidity
patients
with
for
researchers,
clinicians
healthcare
providers.
Conclusion
The
Western
diet
microbial
perturbation
serve
as
fuel
inflammation
beyond
gut.
syndrome
increasingly
affect
IBD,
expected
negative
impact
both
risk
complications.
This
concept
implies
that
tackling
obesity
pandemic
exerts
beneficial
effects
health.
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Сен. 28, 2024
Excessive
accumulation
of
reactive
oxygen
and
nitrogen
species
(RONS)
dysbiosis
intestinal
microbiota
are
pivotal
symptoms
for
inflammatory
bowel
disease
(IBD)
its
associated
complications,
such
as
fibrosis.
This
research
introduces
a
probiotic
inulin
hydrogel
loaded
with
polypyrrole
(PPy)
nanozymes
antifibrotic
drug
pirfenidone
(PFD)
(PPy/PFD@Inulin
gel)
designed
the
concurrent
amelioration
IBD
fibrotic
complication.
Upon
oral
administration,
gel
matrix
could
extend
gastrointestinal
residence
time
PPy
PFD,
facilitating
efficient
reduction
pro-inflammatory
cytokine
levels
enhancement
epithelial
barrier
repair
well
suppression
fibrosis
through
sustained
RONS
scavenging,
modulation
gut
attenuation
TGF-β/Smad
signaling
pathway
to
inhibit
fibroblast
proliferation.
Notably,
PPy/PFD@Inulin
demonstrated
significant
prophylactic
therapeutic
efficacy
in
acute
chronic
colitis
induced
by
dextran
sodium
sulfate
(DSS)
mouse
models.
Thus,
engineered
ternary
offered
pioneered
paradigm
simultaneous
reversal
fibrosis,
single
regimen.
Microplastics,
as
an
emerging
environmental
pollutant,
have
received
widespread
attention
for
their
potential
impact
on
ecosystems
and
human
health.
Microplastics
are
defined
plastic
particles
less
than
5
millimeters
in
diameter
can
be
categorized
primary
secondary
microplastics.
Primary
microplastics
usually
originate
directly
from
industrial
production,
while
formed
by
the
degradation
of
larger
items.
capable
triggering
cytotoxicity
chronic
inflammation,
may
promote
cancer
through
mechanisms
such
pro-inflammatory
responses,
oxidative
stress
endocrine
disruption.
In
addition,
improved
bring
new
perspectives
to
therapy,
studies
drug
carriers
underway,
showing
high
targeting
bioavailability.
Although
current
suggest
association
between
certain
cancers
(e.g.,
lung,
liver,
breast
cancers),
long-term
effects
specific
still
need
studied.
This
review
aimed
at
exploring
carcinogenicity
promising
applications
therapy
provides
important
directions
future
research
emphasizes
multidisciplinary
collaboration
address
this
global
health
challenge.
ABSTRACT
The
gut
microbiota
is
closely
associated
with
inflammatory
bowel
disease
(IBD)
and
colorectal
cancer
(CRC).
Probiotics
such
as
Clostridium
butyricum
(CB)
or
Akkermansia
muciniphila
(AKK)
have
the
potential
to
treat
However,
research
on
combined
therapeutic
effects
immunomodulatory
mechanisms
of
CB
AKK
in
treating
IBD
CRC
has
never
been
studied.
This
study
evaluates
co-administration
DSS/AOM-induced
colitis-associated
CRC.
Our
results
indicate
that
compared
mono-administration,
not
only
significantly
alleviates
symptoms
weight
loss,
colon
shortening,
increased
Disease
Activity
Index
mice
but
also
regulates
composition
effectively
suppresses
colonic
responses.
In
model,
a
combination
loss
markedly
reduces
infiltration
macrophages
cytotoxic
T
lymphocytes
(CTLs)
colon,
thereby
regulating
anti-tumor
immunity
inhibiting
occurrence
inflammation-induced
addition,
we
found
probiotic
therapy
can
enhance
sensitivity
immune
checkpoint
inhibitor
anti-mouse
PD-L1
(aPD-L1),
improving
efficacy
immunotherapy
survival
rate
mice.
Furthermore,
fecal
transplantation
showed
transplanting
feces
from
treated
into
other
alleviated
tumor
loads
extended
their
rate.
suggests
use
two
probiotics,
AKK,
alleviate
chronic
intestinal
inflammation
inhibit
progression
may
be
natural
relatively
safe
method
support
host’s
against
cancer.
IMPORTANCE
administration
opposed
single
strain,
holds
considerable
promise
preventing
advancement
synergistic
effect
attributed
ability
this
more
modulate
microbiota,
curb
reactions,
bolster
immunotherapeutic
approaches,
optimize
treatment
via
transplantation.
Environment International,
Год журнала:
2025,
Номер
195, С. 109258 - 109258
Опубликована: Янв. 1, 2025
Nanoplastics
(NPs)
have
attracted
widespread
attention
owing
to
their
presence
in
the
body.
Recent
studies
highlighted
detrimental
effects
of
NPs
on
digestive
tract.
However,
no
reported
an
association
between
exposure
and
colitis-associated
cancer
(CAC).
An
azoxymethane/dextran
sodium
sulfate-induced
CAC
model
was
used,
polystyrene
nanoparticles
(PS-NPs)
were
selected
for
long-term
exposure.
Non-targeted
metabolomics
16S
rRNA
sequencing
used
detect
changes
colonic
metabolites
gut
microbes
following
PS-NPs
A
lipopolysaccharide
(LPS)-treated
cell
(Caco-2)
exposed
investigate
underlying
molecular
mechanism.
Compared
normal
control
group,
mice
group
exhibited
more
tumor
nodes
reactive
oxygen
species
(ROS),
higher
expression
pan-CK
Ki-67,
severe
DNA
damage.
revealed
that
altered
abundance
Allobaculum
Lactobacillus,
whereas
metabolic
analysis
showed
most
significant
enriched
mostly
fatty
acid
metabolism.
Experiments
LPS
intervened
Caco-2
cells
led
lipid
peroxidation,
oxidative
stress,
damage
Caco-2.
Exposure
activated
phosphatidylinositol
3-kinase
(PI3K)/AKT/mammalian
target
rapamycin
(mTOR)
signaling
pathway
both
AOM/DSS
mouse
cellular
model.
Key
proteins
involved
metabolism
downregulated
PS-NPs.
The
significantly
inhibited
by
activation
fenofibrate.
disturbed
induced
via
PI3K/AKT/mTOR
promote
progression.
Inhibition
is
a
therapeutic
controlling
PS-NP-induced
CAC.
Our
study
provides
important
reference
prevention
treatment
from
perspective
environment
enhances
awareness
necessity
plastic
control.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(2), С. 610 - 610
Опубликована: Янв. 13, 2025
The
pentose
phosphate
pathway
(PPP),
traditionally
recognized
for
its
role
in
generating
nicotinamide
adenine
dinucleotide
(NADPH)
and
ribose-5-phosphate
(R5P),
has
emerged
as
a
critical
metabolic
hub
with
involvements
various
gastrointestinal
(GI)
cancers.
PPP
plays
crucial
roles
the
initiation,
development,
tumor
microenvironment
(TME)
of
GI
cancers
by
modulating
redox
homeostasis
providing
precursors
nucleotide
biosynthesis.
Targeting
enzymes
their
regulatory
axis
been
potential
strategy
anti-GI
cancer
therapies.
In
this
review,
we
summarize
mechanisms
enzymes,
elucidate
relationships
between
TME's
elements,
discuss
therapeutic
targeting